Abacavir, dolutegravir, and lamivudine and Nuwiq recombinant
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Nuwiq recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Nuwiq (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-NuZole
- Abacavir, dolutegravir, and lamivudine-Nuzyra
- Abacavir, dolutegravir, and lamivudine-Nuzyra (Omadacycline Injection)
- Abacavir, dolutegravir, and lamivudine-Nuzyra (Omadacycline Tablets)
- Abacavir, dolutegravir, and lamivudine-Nuzyra Intravenous
- Abacavir, dolutegravir, and lamivudine-Nuzyra oral/injection
- Nuwiq recombinant-Abacavir, Lamivudine and Zidovudine Tablets
- Nuwiq recombinant-Abacavir, lamivudine, and zidovudine
- Nuwiq recombinant-Abaloparatide
- Nuwiq recombinant-Abaloparatide Subcutaneous
- Nuwiq recombinant-Abatacept
- Nuwiq recombinant-Abatacept Auto-Injectors